Inhibitory effects of pre-ischemic and post-ischemic treatment with FR 168888, a Na+/H+ exchange inhibitor, on reperfusion-induced ventricular arrhythmias in anesthetized rat

Japanese Journal of Pharmacology

Volumn 88, Issue 1, 2002, Pages 93-99

  Zhu, Bing Mei ^a   Miyamoto, Shigeki ^a   Kamiya, Kazunori ^a   Komori, Sadayoshi ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Arrhythmia; FR 168888; Ischemia; Na+ H+ exchange; Reperfusion

Indexed keywords

5 HYDROXYMETHYL 3 (PYRROL 1 YL)BENZOYLGUANIDINE METHANESULFONATE; FR 168888; PROTEIN INHIBITOR; SODIUM PROTON EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BLOOD PRESSURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; INCIDENCE; INHIBITION KINETICS; MALE; MORTALITY; NONHUMAN; RAT; TREATMENT PLANNING;

EID: 0036169037     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.88.93     Document Type: Article

References (31)

1. + exchanger contributes to cardiac damage following ischemia and reperfusion
2. 2+ exchange
3. Amiloride delays the ischemia induced rice in cytosolic free calcium
4. The role of sodium-proton exchange in ischemia-reperfusion injury in the heart
5. Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy
6. 2+ overload and prolonged acidosis on reperfusion
7. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischemia and reperfusion
8. + exchange on reperfusion related myocardial injury and arrhythmias in an open-chest swine model
9. + exchange inhibitor, on ventricular arrhythmias in animal hearts
10. + exchange inhibitor, on reperfusion ventricular arrhythmias in rat hearts
11. + exchange ischemia-reperfusion injury after hypothermic cardioplegic arrest
12. + exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: In comparison with other cardioprotective compounds
13. Effects of NS-2, a new class I antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: Comparison with disopyramide and mexiletine
14. Ischemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: Implications for mechanism of initiation and maintenance of ventricular fibrillation
15. 'Dose'-dependency and temporal characteristics of protection by ischemic preconditioning against ischemia-induced arrhythmias in rat hearts
16. Intracellular calcium and electrogram in ischemic isolated rat heart
17. The Lambeth conventions: Guidelines for the study of arrhythmias in ischemia, infarction and reperfusion
18. 2 antagonists
19. Some statistical methods useful in circulation research
20. Models for the study of arrhythmias in myocardial ischaemia and infarction: The use of the rat
21. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH
22. + exchanger
23. Effect of intracellular and extracellular pH on contraction in isolated mammalian cardiac muscle
24. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia
25. + exchange inhibitors
26. The coronary collateral circulation during regional myocardial ischemia: A comparative study in eight species
27. + exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA
28. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion
29. +-exchange inhibitor, FR 183998, shows cardioprotective effects in rats with cardiac ischemia and reperfusion
30. 23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion
31. + exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation